Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Twist Bioscience Corporation (TWST) Q2 2024 Earnings Call Transcript
10:54pm, Thursday, 02'nd May 2024
Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs Emily Leproust - Chie
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
06:36pm, Thursday, 02'nd May 2024
Twist Bioscience (TWST) came out with a quarterly loss of $0.79 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.06 per share a year ago.
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
03:20pm, Tuesday, 30'th Apr 2024
Biotech stocks offer the opportunity to invest in life-saving treatments and drugs. So not only can you make massive gains but you are also investing in the advancement of modern medicine.
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
08:00am, Thursday, 18'th Apr 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
08:00am, Thursday, 28'th Mar 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
08:00am, Tuesday, 05'th Mar 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
7 Stocks Cathie Wood Is Still Loading Up On in Q1
01:59pm, Tuesday, 13'th Feb 2024
You can't say Cathie Wood is afraid to make big bets. The investing guru is more than willing to lay it all on the line for stocks she believes in.
7 Sexy Stocks That Will Continue to Outperform in 2024
03:44pm, Sunday, 11'th Feb 2024
While 2023 was the year of the Magnificent Seven, the seven outperforming stocks in this article are likely to be winners that will surge past the broader indices, such as the S&P 500 and the Nasdaq.
Twist Bioscience: Strong Performance In A Soft Market
09:22am, Wednesday, 07'th Feb 2024
Twist Bioscience reported strong results in the first quarter of FY2024, despite a tepid demand environment. Growth was somewhat exaggerated by lumpy NGS revenue, but overall the business is progressi
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:00am, Wednesday, 07'th Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a company enabling cu
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
08:05am, Tuesday, 06'th Feb 2024
SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
08:00am, Monday, 05'th Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript
01:11pm, Friday, 02'nd Feb 2024
Twist Bioscience Corporation (TWST) Q1 2024 Earnings Call Transcript
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
07:30am, Friday, 02'nd Feb 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience Expands Express Genes Rapid Synthesis Service
08:00am, Wednesday, 24'th Jan 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
